Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism
Plasma aldosterone concentration (PAC) was routinely measured using radioimmunoassay (RIA); however, the RIA kit was discontinued in March 2021 in Japan. This study examined PAC conversion in adrenal venous sampling (AVS) and AVS criteria when measured using chemiluminescent enzyme immunoassay (CLEI...
Saved in:
Main Authors: | Kazuki Nakai, Yuya Tsurutani, Koki Irie, Kyoko Teruyama, Sachiko Suematsu, Seishi Matsui, Kohzoh Makita, Jun Saito, Masao Omura, Tetsuo Nishikawa |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2024-05-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/71/5/71_EJ23-0695/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan
by: Ken-ichiro Honma, et al.
Published: (2024-09-01) -
Comparative Analysis of Liquid Chromatography-Tandem Mass Spectrometry and Radioimmunoassay in Determining Plasma Aldosterone Concentration and Plasma Renin Activity for Primary Aldosteronism Screening
by: So Yoon Kwon, et al.
Published: (2024-12-01) -
Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01) -
Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights
by: Takumi Kitamoto, et al.
Published: (2025-01-01) -
Diagnostic uncertainty in primary aldosteronism
by: Marković Bojan, et al.
Published: (2024-01-01)